CoreWeave, a company specializing in providing infrastructure for artificial intelligence projects, has signed a $14.2 billion deal with Meta. The multi-year agreement involves the delivery of computing power to support the development and training of advanced AI models within the Meta ecosystem.
This partnership is part of a broader trend of growing demand for specialized AI infrastructure. CoreWeave, as one of the leaders in the so-called neocloud segment—companies renting access to the most advanced chips—is rapidly strengthening its position in this sector. In recent months, the company has significantly expanded its client base, securing not only Meta but also OpenAI, among others.
Thanks to these new contracts, the company is becoming less dependent on its previous main source of revenue—Microsoft. This diversification is a strategic response to the rapidly evolving market, where more and more players are investing heavily in the development of their own AI solutions. This year alone, Meta plans to spend up to $72 billion on data centers and computing infrastructure.
Like its competitors, CoreWeave is financing its growth primarily through debt issuance, a practice that is becoming increasingly common in this sector. Recently, other players such as Meta and Oracle have taken similar steps, raising billions of dollars to fund the development of AI-related infrastructure.
Source: xStation5
TSMC Earnings Preview: Will the Key Semiconductor Supplier Surprise the Market?
US Open: American Indices Rally on Anticipated End of Fed Balance Sheet Reduction
Bank of America, Wells Fargo, and Morgan Stanley: Q3 2025 Earnings Overview
Abbott reports no surprises in Q3, but tariff risks and lowered forecasts drag the share price down💡
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.
